Cash & equivalents decreased 28.0%
Cash & equivalents changed -28.0% from the comparable as-filed period.
$60.5M→$43.5M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →RBBN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross profit decreased 17.3%
Gross profit changed -17.3% from the comparable as-filed period.
$109.3M→$90.3M3 prior comparisons
Net income decreased 142.2%
Net income changed -142.2% from the comparable as-filed period.
-$11.1M→-$26.9M3 prior comparisons
Operating income decreased 389.1%
Operating income changed -389.1% from the comparable as-filed period.
$4.2M→-$12.2M3 prior comparisons
Operating margin moved 827 bp lower
Operating margin changed -827 basis points from the comparable as-filed period.
1.92%→-6.35%3 prior comparisons
Revenue decreased 12.8%
Revenue changed -12.8% from the comparable as-filed period.
$220.6M→$192.3M3 prior comparisons
Gross margin moved 258 bp lower
Gross margin changed -258 basis points from the comparable as-filed period.
49.55%→46.97%3 prior comparisons
Inventory increased 9.4%
Inventory changed +9.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$80.3M→$87.8M4 prior comparisons
Stock-based compensation increased 7.9%
Stock-based compensation changed +7.9% from the comparable as-filed period.
$4.5M→$4.8M3 prior comparisons
Debt decreased 2.5%
Debt changed -2.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$346.5M→$337.8M4 prior comparisons
Research & development increased 0.4%
Research & development changed +0.4% from the comparable as-filed period.
$44.7M→$44.9M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.